From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, mainly due to ...
Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...
Daily Mail on MSN
New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds
A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results